CWP232228
- Product Name
- CWP232228
- CAS No.
- 1144044-02-9
- Chemical Name
- CWP232228
- Synonyms
- CWP232228;CWP232228?sodium;CWP232228 disodium;Beta catenin,Wnt,Breast,β-catenin,Inhibitor,CWP232228,CWP 232228,cells,signaling,stem,Cancer,inhibit,liver,CWP-232228;Sodium 4-(((6S,9aS)-2-allyl-1-(benzylcarbamoyl)-8-((2-methyl-2H-indazol-7-yl)methyl)-4,7-dioxooctahydro-1H-pyrazino[2,1-c][1,2,4]triazin-6-yl)methyl)phenyl phosphate
- CBNumber
- CB33354107
- Molecular Formula
- C33H37N7NaO7P
- Formula Weight
- 697.66
- MOL File
- 1144044-02-9.mol
CWP232228 Property
- form
- Solid
- color
- White to off-white
- InChIKey
- RCZZPLXBWBXLAA-RYRAPZCFNA-N
- SMILES
- C(N1N(CC(=O)N2[C@H](C(=O)N(CC3=CC=CC4=CN(C)N=C34)C[C@]12[H])CC1C=CC(OP(O)(O)=O)=CC=1)CC=C)(=O)NCC1C=CC=CC=1.[NaH] |&1:7,23,r|
N-Bromosuccinimide Price
- Product number
- CS-0014678
- Product name
- CWP232228
- Purity
- 98.31%
- Packaging
- 5mg
- Price
- $650
- Updated
- 2021/12/16
- Product number
- CS-0014678
- Product name
- CWP232228
- Purity
- 98.31%
- Packaging
- 10mg
- Price
- $980
- Updated
- 2021/12/16
CWP232228 Chemical Properties,Usage,Production
Uses
CWP232228, a highly potent selective Wnt/β-catenin signaling inhibitor, antagonizes binding of β-catenin to T-cell factor (TCF) in the nucleus. CWP232228 suppresses tumor formation and metastasis without toxicity through the inhibition of the growth of breast and liver cancer stem cells (CSCs)[1].
in vivo
CWP232228 (100 mg/kg, administered i.p.; daily; 21days for mice bearing 4T1 cell tumors; 60 days for mice bearing MDA-MB-435 cell tumors) results in a significant reduction in tumor volume[1].
| Animal Model: | 7-week-old female Balb/c and NOD/SCID mice bearing 4T1 or MDA-MB-435 cell tumors[1] |
| Dosage: | 100 mg/kg |
| Administration: | Administered i.p.; daily; 21days for mice bearing 4T1 cell tumors, 60 days for mice bearing MDA-MB-435 cell tumors |
| Result: | Treatment resulted in a significant reduction in tumor volume. |
References
[1] Jang GB, et al. Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells. Cancer Res. 2015 Apr 15;75(8):1691-702. DOI:10.1158/0008-5472.CAN-14-2041
[2] Kim JY, et al. Oncotarget. 2016 Apr 12;7(15):20395-409. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment. DOI:10.18632/oncotarget.7954
CWP232228 Preparation Products And Raw materials
Raw materials
Preparation Products
CWP232228 Suppliers
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- +1-781-999-5354;
- support@targetmol.com
- Country
- United States
- ProdList
- 39035
- Advantage
- 58
- Tel
- tp@aladdinsci.com
- Country
- United States
- ProdList
- 52923
- Advantage
- 58